331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster III

Epik L1 A Phase 2 3 study of alpelisib in pediatric and adult patients with PIK3CA driven lymphatic malformations

Maternal and fetal outcomes in immune mediated thrombotic thrombocytopenic purpura A scoping review

Clinical manifestations management and outcomes in patients with triple positive antiphospholipid antibodies

Medical and perioperative management of acute and subacute heparin induced thrombocytopenia in adults requiring urgent cardiopulmonary bypass surgery

Review of the management of patients with immune thrombotic thrombocytopenic purpura with persistently low adamts 13 activity a challenge beyond rarity

Pegcetacoplan for patients with transplant associated thrombotic microangiopathy treatment A real world report of six cases

High rates of hypertension improved renal outcomes in complement mediated thrombotic microangiopathy

Daratumumab for immune mediated thrombotic thrombocytopenic purpura iTTP Results from the international multicenter darttp study

Ophthalmic manifestations of antiphospholipid syndrome

Real world outcomes of platelet transfusion in heparin induced thrombocytopenia A five year national study

High morbidity and early readmissions in thrombotic thrombocytopenic purpura requiring intensive care Insights from a national database